Objectives

After participating in this educational activity, attendees should be able to:
1. Describe the investigator’s responsibilities when conducting a trial 
2. Identify and analyze the IRB assessment of ethical and regulatory responsibilities 
3. Analyze the ethical and practical issues surrounding the risk to subjects when designing and implementing protocols
4. Analyze how lessons learned from previous cases of abuse can help inform protections for future research subjects
5. List the four levels of scale of measurement of variables
6. Explain the difference between a dependent variable and independent variable 
7. Discuss the distinction between “statistical significance” and “clinical significance”
8. List three reasons for conducting pilot studies

Faculty

Jennifer Pacheco MPH
Chief Research Compliance Officer
Director, Healthcare Research Compliance
UMMS-Baystate 

Paul Visintainer, PhD
Professor of Medicine, UMMS-Baystate
Director, Scientific Integrity & Analytics
Director of Epidemiology & Biostatistics
Baystate Health


Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.

Session date: 
Thursday, March 19, 2020 - 8:00am to 10:15am
Location: 
UMMS-Baystate
3601 Main Street
Room 337
Springfield, MA 01199
United States
  • 2.00 AMA PRA Category 1 Credit™

Please login or register to take this course.